Ticker name:MIRA MIRA PHARMACEUTICALS, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

Market Cap 41M

Last close 0.968$

Largest 17 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co960B1018.87$
2AZNASTRAZENECA PLC581B187.46$
3JNJJOHNSON & JOHNSON552B229.32$
4ABBVAbbVie Inc.375B212.3$
5NVSNOVARTIS AG287B150.45$
6MRKMerck & Co., Inc.279B113$
7AMGNAMGEN INC179B331.57$
8GILDGILEAD SCIENCES, INC.162B130.69$
9PFEPFIZER INC147B25.79$
10BMYBRISTOL MYERS SQUIBB CO120B58.54$
11SNYSanofi109B44.67$
12BIIBBIOGEN INC.28B187.8$
13OGNOrganon & Co.3.5B13.46$
14CTORCITIUS ONCOLOGY, INC.77M0.826$
15SRXHSRx Health Solutions, Inc.69M0.1175$
16SCLXScilex Holding Co51M6.01$
17MIRAMIRA PHARMACEUTICALS, INC.41M0.9676$